Incyte and Genesis collaborate on small-molecule medicines
Genesis will obtain a $30m upfront payment and the collaboration will initially focus on two targets.
Mimotopes Early R&D projects
Basilea wins CARB-X grant for new antibody development
Bayer and Broad Institute extend cancer therapy development programme
Prelude and AbCellera jump on the ADC train with partnership
Gilead and Assembly Biosciences partner to develop antiviral therapies
Researchers publish early results with new interleukin-targeting antibody
SK bioscience and Doherty Institute partner on flu vaccine research
Psylo signs research deal with Daiichi Sankyo for psychiatric therapies
